Cargando…

Financial Incentives and Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM): a trial protocol

INTRODUCTION: Given the burden of diabetes in ethnic minorities and emerging data on the efficacy of financial incentives in type 2 diabetes mellitus (T2DM), it is critical to examine the efficacy of financial incentives across and within racial/ethnic groups. METHODS AND ANALYSIS: This trial is an...

Descripción completa

Detalles Bibliográficos
Autores principales: Egede, Leonard E, Walker, Rebekah, Williams, Joni S, Knapp, Rebecca, Dismuke, Clara Elizabeth, Davidson, Tatiana, Campbell, Jennifer A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757449/
https://www.ncbi.nlm.nih.gov/pubmed/33371048
http://dx.doi.org/10.1136/bmjopen-2020-043760
_version_ 1783626752163053568
author Egede, Leonard E
Walker, Rebekah
Williams, Joni S
Knapp, Rebecca
Dismuke, Clara Elizabeth
Davidson, Tatiana
Campbell, Jennifer A
author_facet Egede, Leonard E
Walker, Rebekah
Williams, Joni S
Knapp, Rebecca
Dismuke, Clara Elizabeth
Davidson, Tatiana
Campbell, Jennifer A
author_sort Egede, Leonard E
collection PubMed
description INTRODUCTION: Given the burden of diabetes in ethnic minorities and emerging data on the efficacy of financial incentives in type 2 diabetes mellitus (T2DM), it is critical to examine the efficacy of financial incentives across and within racial/ethnic groups. METHODS AND ANALYSIS: This trial is an ongoing 5-year, randomised clinical trial designed to test the efficacy of a Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM) intervention composed of (1) nurse education, (2) home telemonitoring and (3) structured financial incentives; compared with an active control group (nurse education and home telemonitoring alone). The study also will evaluate whether intervention effects are sustained 6 months after the financial incentives are withdrawn (ie, 18 months post-randomisation) and whether the intervention is differentially efficacious across racial/ethnic groups. Participants will include 450 adults with a clinical diagnosis of T2DM and HbA1c of 8% or higher who self-identify as White, African American or Hispanic. Participants will be randomised to one of two groups: the FINANCE intervention or Active Control. The location and setting of this study include primary care clinics at the Medical College of Wisconsin (MCW) in Milwaukee, WI and community partner sites affiliated with the Center for Advancing Population Science at MCW. ETHICS AND DISSEMINATION: This trial was approved by IRB at MCW under PRO00033788. TRIAL REGISTRATION NUMBER: Registration for this trial on the United States National Institute of Health Clinical Trials Registry can be found under ID: NCT04203173 and online (https://clinicaltrials.gov/ct2/show/NCT04203173?id=NCT04203173&draw=2&rank=1).
format Online
Article
Text
id pubmed-7757449
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-77574492020-12-28 Financial Incentives and Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM): a trial protocol Egede, Leonard E Walker, Rebekah Williams, Joni S Knapp, Rebecca Dismuke, Clara Elizabeth Davidson, Tatiana Campbell, Jennifer A BMJ Open Diabetes and Endocrinology INTRODUCTION: Given the burden of diabetes in ethnic minorities and emerging data on the efficacy of financial incentives in type 2 diabetes mellitus (T2DM), it is critical to examine the efficacy of financial incentives across and within racial/ethnic groups. METHODS AND ANALYSIS: This trial is an ongoing 5-year, randomised clinical trial designed to test the efficacy of a Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM) intervention composed of (1) nurse education, (2) home telemonitoring and (3) structured financial incentives; compared with an active control group (nurse education and home telemonitoring alone). The study also will evaluate whether intervention effects are sustained 6 months after the financial incentives are withdrawn (ie, 18 months post-randomisation) and whether the intervention is differentially efficacious across racial/ethnic groups. Participants will include 450 adults with a clinical diagnosis of T2DM and HbA1c of 8% or higher who self-identify as White, African American or Hispanic. Participants will be randomised to one of two groups: the FINANCE intervention or Active Control. The location and setting of this study include primary care clinics at the Medical College of Wisconsin (MCW) in Milwaukee, WI and community partner sites affiliated with the Center for Advancing Population Science at MCW. ETHICS AND DISSEMINATION: This trial was approved by IRB at MCW under PRO00033788. TRIAL REGISTRATION NUMBER: Registration for this trial on the United States National Institute of Health Clinical Trials Registry can be found under ID: NCT04203173 and online (https://clinicaltrials.gov/ct2/show/NCT04203173?id=NCT04203173&draw=2&rank=1). BMJ Publishing Group 2020-12-22 /pmc/articles/PMC7757449/ /pubmed/33371048 http://dx.doi.org/10.1136/bmjopen-2020-043760 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Diabetes and Endocrinology
Egede, Leonard E
Walker, Rebekah
Williams, Joni S
Knapp, Rebecca
Dismuke, Clara Elizabeth
Davidson, Tatiana
Campbell, Jennifer A
Financial Incentives and Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM): a trial protocol
title Financial Incentives and Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM): a trial protocol
title_full Financial Incentives and Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM): a trial protocol
title_fullStr Financial Incentives and Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM): a trial protocol
title_full_unstemmed Financial Incentives and Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM): a trial protocol
title_short Financial Incentives and Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM): a trial protocol
title_sort financial incentives and nurse coaching to enhance diabetes outcomes (finance-dm): a trial protocol
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757449/
https://www.ncbi.nlm.nih.gov/pubmed/33371048
http://dx.doi.org/10.1136/bmjopen-2020-043760
work_keys_str_mv AT egedeleonarde financialincentivesandnursecoachingtoenhancediabetesoutcomesfinancedmatrialprotocol
AT walkerrebekah financialincentivesandnursecoachingtoenhancediabetesoutcomesfinancedmatrialprotocol
AT williamsjonis financialincentivesandnursecoachingtoenhancediabetesoutcomesfinancedmatrialprotocol
AT knapprebecca financialincentivesandnursecoachingtoenhancediabetesoutcomesfinancedmatrialprotocol
AT dismukeclaraelizabeth financialincentivesandnursecoachingtoenhancediabetesoutcomesfinancedmatrialprotocol
AT davidsontatiana financialincentivesandnursecoachingtoenhancediabetesoutcomesfinancedmatrialprotocol
AT campbelljennifera financialincentivesandnursecoachingtoenhancediabetesoutcomesfinancedmatrialprotocol